Deficits in quality end-of-life care for nursing home (NH) residents are well known.
6 Studies in England have focused mainly on diabetes, heart disease, and asthma, and found widespread deficits in quality of care, although recent studies have reported some improvements.
This results in deficits in quality of care on the one hand and high patient co-payments on the other [ 3].
Individuals undergoing hematopoietic stem cell transplant (HSCT) experience significant deficits in quality of life that may persist months or even years after HSCT.
Service redesign, education and staff stability must be a priority to redress serious deficits in quality of care provided for these infants.
2 Deficits in quality of care have been reported from many high income countries, 3 4 5 with a comprehensive study on quality in the United States finding that adults received only 55% of recommended care in 1998-2000.
In considering the limitations of this review, it is worthy of note that the majority of cited studies concentrate on deficits in quality of care, and this may reflect publication bias to some extent.
It has been associated with deficits in quality of life and psychological adjustment, disability, reduced income potential, high levels of health care utilization and high costs to private industry.
Frequently these patients, especially with acute respiratory distress syndrome, present neurocognitive impairments [ 1] that extend beyond their acute phase and hospital stay and lead to significant deficits in quality of life [ 2, 3].
The study from Bagnenko et al. [ 34] was excluded because of missing data and deficits in quality: the inclusion of patients was not clearly described, the exact number of patients treated in each group was not given, for hospital mortality only percentages without absolute numbers were reported, and finally the treatment regimen for the control group was not specified.
